Navigation Links
Lung Cancer May Be Deadlier for Men
Date:11/13/2008

Gender is the major socioeconomic factor influencing outcomes, study finds

THURSDAY, Nov. 13 (HealthDay News) -- Men are more likely to die from inoperable non-small cell lung cancer than women, U.S. researchers report.

In fact, gender is the most important factor influencing overall survival of patients with this disease, the new study found.

A team of researchers in six U.S. cities studied 1,365 patients enrolled in national group trials to determine the effect of such sociodemographic factors as gender, race and marital status on lung cancer outcomes.

They found that men had a 1.23 times higher death rate than women, while race and marital status didn't significantly affect outcomes.

"Our study corroborates the fact that gender plays an important role as a prognostic factor in people diagnosed with lung cancer," the lead author, Dr. Benjamin Movsas, chair of the radiation oncology department at Henry Ford Hospital in Detroit, said in a news release. "This underscores the importance of studying this disease entity in light of the fact that women diagnosed with lung cancer tend to have a better outcome in terms of survival."

The study was to be presented Thursday at the Chicago Multidisciplinary Symposium in Thoracic Oncology.

At the same meeting, another group of U.S. researchers, from the South West Oncology Group, reported that a combination of traditional chemotherapy with targeted therapies called monoclonal antibodies was safe and improved survival of patients with advanced non-small cell lung cancer.

The study found that the use of two targeted therapies (bevacizumab and cetuximab) with chemotherapy (carboplatin and paclitaxel) as first-line treatment improved the survival of 104 patients who were evaluated between August 2006 and September 2007. There were no safety concerns.

"The combination of multiple targeted therapies in addition to chemotherapy may be the future of treatment in lung cancer," lead author Dr. Edward Kim, an assistant professor in the department of thoracic/head and neck medical oncology at M.D. Anderson Cancer Center in Houston, said in a news release. "Blocking more key cancer pathways such as the epidermal growth factor receptor and vascular endothelial growth factor may lead to improved cancer control."

In 2008, about 215,000 new cases of lung cancer will be diagnosed in the United States and 161,840 people will die from the disease, according to the U.S. National Cancer Institute.

More information

The American Cancer Society has more about non-small cell lung cancer.



-- Robert Preidt



SOURCE: American Society for Therapeutic Radiology and Oncology, news releases, Nov. 13, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cancer treatment may result in bone loss
2. American Academy of Dermatology: Stop Skin Cancer On The Spot
3. Gender is key factor in determining overall survival of lung cancer patients
4. Proton therapy may reduce serious side effect of lung cancer treatment
5. Tissue analyses indicate survival benefits for some lung cancer patients
6. Advanced lung cancer patients see improved, progression-free survival
7. Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients
8. Research demonstrates differing genetic makeup of lung cancer in African-American patients
9. Novel 4-drug combination proves safe for lung cancer treatment
10. US Oncology Applauds Senator Baucuss Healthcare Reform Call to Action for 2009, Supports Collaborative Measures to Enhance Cancer Patients Access to Care While Improving Quality and Access
11. AACR to host 7th Annual International Conference on Frontiers in Cancer Prevention Research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lung Cancer May Be Deadlier for Men
(Date:2/10/2016)... PLAINSBORO, N.J. (PRWEB) , ... ... ... J. Hennessy Associates, Inc. , a full-service health care communications company offering ... integrated digital news resource for practitioners and specialists working in infectious diseases. ...
(Date:2/10/2016)... ... February 10, 2016 , ... As part of its ongoing ... February 2016. Each webinar features a dynamic expert and thoughtful presentation to give ... patients and facilities. Both events are free to attend, but registration is ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... solution, The Guard, to associations of medical professionals throughout the country. The Guard ... security risk assessments, policies and procedures, employee training, regulatory updates, and compliance coaching. ...
(Date:2/10/2016)... ... February 10, 2016 , ... 10 Best Water is excited ... bottled water brand owners that topped the list as a result of their commitment ... The premier brand was Tibet 5100, a top notch water company that specializes in ...
(Date:2/10/2016)... ... ... Ongoing news of the ravages of traumatic brain injury (TBI) among former NFL ... a closer look at cases of TBI being managed by their members. The survey ... aging population, and identifies the challenges associated with their care. , During the week ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Feb. 10, 2016 CSI Specialty Group (CSI) ... launch of the Specialty Pharmacy Podcast. A free, weekly ... at providing real-world education, discussion and context amongst specialty ... --> The Specialty Pharmacy Podcast, ... CSI Specialty Group Suzette DiMascio, CHE, CMCE, CPC, is ...
(Date:2/10/2016)... WOONSOCKET, R.I. , Feb. 10, 2016  CVS ... vaccines to people living in Santa Clara ... of Meningitis B on the Santa Clara University campus. ... vaccines available to protect patients against the disease. Students ... are encouraged to get vaccinated. In addition, anyone who ...
(Date:2/10/2016)... Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: ... 1-for-100 reverse split of its issued and outstanding shares ... on Thursday, February 11, 2016. The Company,s common stock ... number 76303T308 and temporary ticker symbol "RCHAD". After 20 ... the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology: